Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis.
about
P1343
A review of arsenic trioxide and acute promyelocytic leukemiaTaxol induces caspase-10-dependent apoptosisPaclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop.Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway.Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway.Arsenic trioxide, a therapeutic agent for APL.Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation.Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes.Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical and basic studies.Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside.Arsenic trioxide: an anti cancer missile with multiple warheads.Arsenic trioxide mechanisms of action--looking beyond acute promyelocytic leukemia.Arsenic trioxide for management of acute promyelocytic leukemia: current evidence on its role in front-line therapy and recurrent disease.Arsenic trioxide promotes histone H3 phosphoacetylation at the chromatin of CASPASE-10 in acute promyelocytic leukemia cells.Phenylarsine oxide (PAO) more intensely induces apoptosis in acute promyelocytic leukemia and As2O3-resistant APL cell lines than As2O3 by activating the mitochondrial pathway.Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells.Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis.Arsenic trioxide enhances the cytotoxic effect of thalidomide in a KG-1a human acute mylogenous leukemia cell lineArsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis.CD44 ligation induces apoptosis via caspase- and serine protease-dependent pathways in acute promyelocytic leukemia cells.Morphological and biochemical changes induced by arsenic trioxide in neuroblastoma cell lines.Triterpenoid CDDO-Im downregulates PML/RARalpha expression in acute promyelocytic leukemia cells.Vitamin C protects HL60 and U266 cells from arsenic toxicity.In vitro and in vivo effectiveness of arsenic trioxide against murine T-cell prolymphocytic leukaemia.P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) are induced by arsenic trioxide (As(2)O(3)), but are not the main mechanism of As(2)O(3)-resistance in acute promyelocytic leukemia cells.Sustained activation of c-jun-terminal kinase (JNK) is closely related to arsenic trioxide-induced apoptosis in an acute myeloid leukemia (M2)-derived cell line, NKM-1.Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.Gene expression alteration during redox-dependent enhancement of arsenic cytotoxicity by emodin in HeLa cells.The role of mitochondrial targeting in arsenic trioxide-induced apoptosis in myeloid cell lines.Dual effects of arsenic trioxide (As2O3) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation.Arsenic trioxide induces human pulmonary fibroblast cell death via the regulation of Bcl-2 family and caspase-8.
P2860
Q28087768-9EC6BB66-754E-4729-BEBD-9099AFE17140Q28285037-2638EC66-532F-4D7E-815E-3037C526EBC0Q33186742-8E751076-19C2-47AD-B11A-5D18BFEDDB0BQ33211246-14211859-2C87-47D6-8BAE-A93E9368C6FFQ33218586-FA866E4E-C73A-4DE0-8B96-98F564AD2E78Q34435492-DE203744-FADC-4A6C-A0F7-7636C4FE312DQ34435506-9D6C305B-AA1C-4B6B-A106-B520EB161E56Q34435576-3FE2C82D-9B7C-4AC4-875E-AFE0CAA73632Q34575618-9A9EC66F-B08F-4E63-9BF3-935AC502270CQ35994852-0731E228-4704-4C11-863E-C2155758A71BQ36194579-4BEE0EBA-0136-4590-853A-AA9197EBD462Q37307720-7A8B9390-6A09-49EA-AB59-510DD43682B1Q37999067-C5AAC90B-79AF-4C0D-AE2B-CF14742A561FQ38361778-32DA8405-17FA-485C-B973-7DB08A57732AQ39420652-8508780F-95AE-4E4F-86BF-A3D9AA4A01E1Q39506455-A4342F5D-B8A8-4705-9583-F77E989F70F2Q39564543-17CAA1BC-03F9-4297-85D1-4D874FCA259AQ39569681-6E447A82-CD4A-42C3-8AEC-C17DC1EF9C58Q40131977-D64F44DA-03FF-4036-AD1F-42A255487B1AQ40365002-9CB34DA9-EB0C-425E-A219-18667CF00F6BQ40373034-B4895614-4C46-409B-ADFA-CD273A7AD216Q40450776-74E39028-93B2-4D76-AA20-AA8F52EDEDBAQ40464464-D5A0BA53-849E-49C1-B5B9-D34EC6C84A74Q43815919-F91F61E0-3ED6-4C2B-ACF4-810AAB2D5505Q44368794-2B1BA851-E980-4DE3-A6D7-55773509D0DDQ44557861-DCC3B917-E1B1-4857-B2E2-E4C885A8AD7BQ46593571-ADADDEF4-5263-43A9-87D9-D9D98A2D15FFQ46620180-A9C703E1-ADB5-441D-8705-693457D83058Q47307384-7AA5E1A7-74F7-40FE-A3B5-1FB68DC6B754Q52959035-5E7994EE-B0B5-4552-859D-540FAEB94AB4Q53414231-0FCCAE83-4E67-41DA-9BF7-EE0047534B5A
P2860
Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Involvement of CD95-independen ...... ic trioxide-induced apoptosis.
@ast
Involvement of CD95-independen ...... ic trioxide-induced apoptosis.
@en
Involvement of CD95-independen ...... ic trioxide-induced apoptosis.
@nl
type
label
Involvement of CD95-independen ...... ic trioxide-induced apoptosis.
@ast
Involvement of CD95-independen ...... ic trioxide-induced apoptosis.
@en
Involvement of CD95-independen ...... ic trioxide-induced apoptosis.
@nl
prefLabel
Involvement of CD95-independen ...... ic trioxide-induced apoptosis.
@ast
Involvement of CD95-independen ...... ic trioxide-induced apoptosis.
@en
Involvement of CD95-independen ...... ic trioxide-induced apoptosis.
@nl
P2093
P356
P1433
P1476
Involvement of CD95-independen ...... ic trioxide-induced apoptosis.
@en
P2093
Kitamura K
Yamamoto K
P2888
P304
P356
10.1038/SJ.LEU.2401900
P4510
P577
2000-10-01T00:00:00Z
P5875
P6179
1028484710